Omada Health

Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress

SAN FRANCISCO, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, announced it will present research at the World Obesity and Weight Management Congress (WOC 2026) in Boston showing that members of its GLP-1 Care Track lost more weight and experienced greater improvements in body composition than GLP-1 users receiving usual care. The findings were recently published in the peer-reviewed journal Diabetes, Obesity and Metabolism.

Omada Health to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 5, 2026

SAN FRANCISCO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its third quarter 2026 results on Thursday, November 5, 2026, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details A live audio webcast of the call will be available online at https://investors.omadahealth.com.

Reviewing HCA Healthcare (NYSE:HCA) & Omada Health (NASDAQ:OMDA)

HCA Healthcare (NYSE: HCA - Get Free Report) and Omada Health (NASDAQ: OMDA - Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership. Earnings and Valuation This table compares HCA Healthcare

Omada Health, Inc. (NASDAQ:OMDA) Stock Has Average Price Target of $26.67

Omada Health, Inc. (NASDAQ: OMDA - Get Free Report) has been given an average recommendation of "Moderate Buy" by the fourteen analysts that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the

Bank of America Corp DE Acquires 313,440 Shares of Omada Health, Inc. $OMDA

Omada Health (NASDAQ:OMDA) and NeoGenomics (NASDAQ:NEO) Head-To-Head Contrast

NeoGenomics (NASDAQ: NEO - Get Free Report) and Omada Health (NASDAQ: OMDA - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership and dividends. Risk and Volatility NeoGenomics has a beta of 1.75,

Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000

The transaction represented 3% of the insider's direct equity holdings before the filing. The sale was conducted directly through an open-market transaction under a pre-established Rule 10b5-1 trading plan.

Omada Health, Inc. (OMDA) Analyst/Investor Day Transcript

Omada Health, Inc. (OMDA) Analyst/Investor Day Transcript